Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth

Clinical Chemistry

Volumn 56, Issue 9, 2010, Pages 1442-1450

  Gray, Teresa R ^a   Eiden, Rina D ^b   Leonard, Kenneth E ^b   Connors, Gerard J ^b   Shisler, Shannon ^b   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CANNABINOID; CANNABIS;

ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CANNABIS SMOKING; CHILD GROWTH; CIGARETTE SMOKING; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GROWTH RETARDATION; HEAD CIRCUMFERENCE; HUMAN; MECONIUM; NEWBORN; PREGNANT WOMAN; PRENATAL EXPOSURE; SECOND TRIMESTER PREGNANCY; SELF REPORT;

BIOLOGICAL MARKERS; CANNABINOIDS; FEMALE; GROWTH DISORDERS; HUMANS; INFANT, NEWBORN; MARIJUANA ABUSE; MATERNAL-FETAL EXCHANGE; MECONIUM; PREGNANCY; SMOKING;

EID: 77956376715     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.147876     Document Type: Article

References (33)

1. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies (OAS). Results from the 2008 National Survey on Drug Use and Health: national findings. Rockville (MD): SAMHSA, OAS; 2009. http://www.oas.samhsa. gov/nsduh/2k8nsduh/2k8results.cfm (Accessed August 2010).
2. Westfall R, Janssen P, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: Patterns of its use in pregnancy and retroactive self-assessment of its efficacy against "morning sickness." Complement Ther Clin Pract 2006;12:27-33.
3. Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 1986; 124:986-93.
4. El Marroun H, Tiemeier H, Steegers EAP, Jaddoe VWV, Hofman A, Verhulst FC, et al. Intrauterine cannabis exposure affects fetal growth trajectories: The Generation R Study. J Am Acad Child Adolesc Psychiatry 2009;48:1173-81.
5. Dreher MC, Nugent K, Hudgins R. Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study. Pediatrics 1994; 93:254-60. (Pubitemid 24047162)
6. Hayes JS, Lampart R, Dreher MC, Morgan L. Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy. West Indian Med J 1991;40:120-3.
7. Lester B, Dreher M. Effects of marijuana use during pregnancy on newborn cry. Child Dev 1989;60:765-71.
8. Lozano J, Garcia-Algar O, Marchei E, Vall O, Monleon T, Giovannandrea RD, Pichini S. Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr 2007;96:1734-7.
9. Hayes JS, Dreher MC, Nugent JK. Newborn outcomes with maternal marihuana use in Jamaican women. Pediatr Nurs 1988;14:107-10.
10. van Gelder MM, Reefhuis J, Caton AR, Werler MM, Druschel CM, Roeleveld N. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug Alcohol Depend 2010;109:243-7.
11. Goldschmidt L, Richardson G, Willford J, Day N. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry 2008;47:254-63.
12. Gray KA, Day NL, Leech S, Richardson GA. Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age. Neurotoxicol Teratol 2005;27:439-48.
13. Day N, Goldschmidt L, Thomas C. Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14. Addiction 2006;101: 1313-22.
14. Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther 2008;84:604-12.
15. Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, et al. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Evironment and Lifestyle (IDEAL) study. Ther Drug Monit 2009;31:769-75.
16. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J, eds. Measuring alcohol consumption. Totowa (NJ): Humana Press; 1992. p 41-73.
17. Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 1988;83:393-402.
18. Huestis MA, Cone EJ. Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 2004;28: 394-9.
19. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann NY Acad Sci 2007; 1098:51-103.
20. Toennes S, Ramaekers J, Theunissen E, Moeller M, Kauert G. Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J Anal Toxicol 2010;34: 216-21.
21. Gray TR, Barnes A, Huestis M. Effect of hydrolysis on identifying prenatal cannabis exposure. Anal Bioanal Chem 2010;397:2335-47.
22. Gray TR, Shakleya DM, Huestis MA. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Anal Bioanal Chem 2009;393:1977-90.
23. Moore DG, Turner JD, Parrott AC, Goodwin JE, Fulton SE, Min MO, et al. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J Psychopharmacol [Epub ahead of print 2009 Nov 25].
24. Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, et al. Passive cannabis smoke exposure and oral fluid testing. II: two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Tox 2005;29:607-15.
25. Marchei E, Pellegrini M, Pacifici R, Palmi I, Lozano J, Garcia-Algar O, Pichini S. Quantification of delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographicmass spectrometric assay: assay validation and preliminary results of the "Meconium Project." Ther Drug Monit 2006;28:700-6.
26. ElSohly M, Feng S. Delta-9-thc metabolites in meconium: identification of 11-OH-delta-9-THC, 8 beta,11-diOH-delta-9-THC, and 11-nor-delta-9-THC-9-COOH as major metabolites of delta-9- THC. J Anal Toxicol 1998;22:329-35.
27. Coles R, Clements TT, Nelson GJ, McMillin GA, Urry FM. Simultaneous analysis of the Delta9-THC metabolites 11-nor-9-carboxy-Delta9-THC and 11-hydroxy-Delta9-THC in meconium by GC-MS. J Anal Toxicol 2005;29:522-7.
28. Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ. Characterization of the absorption phase of marijuana smoking. Clin Pharm Ther 1992;52:31-41.
29. Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, et al. Cannabinoid concentrations in hair from documented cannabis users. Forensic Sci Internat 2007;169:129-36.
30. El Marroun H, Tiemeier H, Jaddoe VWV, Hofman A, Mackenbach J, Steegers EAP, et al. Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study. Drug Alcohol Depend 2008;98:218-26.
31. United States Department of Health and Human Services. Reproductive effects. In: The health consequences of smoking: a report of the Surgeon General. Atlanta: US Government Printing Office; 2004:550-601.
32. Wilcox M, Gardosi J, Mongelli M, Ray C, Johnson I. Birth weight from pregnancies dated by ultrasonography in a multicultural British population. Br Med J 1993;307:588-91.
33. Hurd YL, Wang X, Anderson V, Beck O, Minkoff H, Dow-Edwards D. Marijuana impairs growth in midgestation fetuses. Neurotoxicol Teratol 2005;27: 221-9.